A Study for the Treatment of Unresectable Stage III or Metastatic Stage IV Melanoma
Clinical trial NCT00281541 · COMPLETED
Trial details
- NCT number
- NCT00281541
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-11-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.